<DOC>
	<DOCNO>NCT00002113</DOCNO>
	<brief_summary>To evaluate estimate safety efficacy combination fluconazole flucytosine treatment acute cryptococcal meningitis patient AIDS . Fluconazole flucytosine different mechanism action . Since fluconazole associate hematologic suppression produce renal impairment result high serum flucytosine level , combination may better tolerate amphotericin B plus flucytosine .</brief_summary>
	<brief_title>A Pilot Study Fluconazole Plus Flucytosine Treatment AIDS Patients With Acute Cryptococcal Meningitis .</brief_title>
	<detailed_description>Fluconazole flucytosine different mechanisms action . Since fluconazole associate hematologic suppression produce renal impairment result high serum flucytosine level , combination may better tolerate amphotericin B plus flucytosine . Patients cohort receive low dose fluconazole alone combination flucytosine , high dose fluconazole alone . Doses subsequent cohort escalate safety data previous cohort satisfactory . Patients evaluate weekly first 4 week every 2 week thereafter . Therapy continue 8 week CSF become culture negative , maximum 26 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Flucytosine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiviral therapy ( AZT , DHPG ) . Prophylaxis Pneumocystis carinii pneumonia . Treatment intercurrent opportunistic infection . Concurrent Treatment : Allowed : Radiation therapy mucocutaneous Kaposi 's sarcoma . Patients must : AIDS . Evidence Cryptococcal neoformans culture lumbar CSF OR clinical CSF finding compatible cryptococcal meningitis . No evidence acute chronic meningitis etiology cryptococcosis . Life expectancy least 2 week . Prior Medication : Allowed : Prior antiviral therapy ( AZT , DHPG ) . Prophylaxis Pneumocystis carinii pneumonia . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Relapsing maintenance triazole therapy cryptococcal meningitis . Unable take oral medication . Concurrent Medication : Excluded : Concomitant use antifungal agent study drug . Patients follow prior condition exclude : History allergy intolerance imidazole , azoles , flucytosine . Prior Medication : Excluded : More 1 mg/kg amphotericin B . Systemic antifungal agent within 7 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1996</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>Cryptococcosis</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Flucytosine</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>